Shenzhen Genocury Biotech Co., Ltd.
3 clinical trials · Sponsor
◉ Watch Shenzhen Genocury Biotech Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| JY232(JY232) Injection in Relapsed/Refractory Multiple Myeloma (NCT07336823) | Shenzhen Genocury Biotech Co., Ltd. | 2026-01-20 |
| JY231(JY231) Injection for the Treatment of Relapsed/Refractory B Cell Lymphoma/ Leukemia (NCT06890065) | Shenzhen Genocury Biotech Co., Ltd. | 2025-03-01 |
Track Shenzhen Genocury Biotech Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.